Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
Nature Materials, 2024
Shi J., Wu W., Chen D., Liao Z., Sheng T., Wang Y., Yao Y., Wu Q., Liu F., Zhou R., Zhu C., Shen X., Mao Z., Ding Y., Wang W., Dotti G., Sun J., Liang X., Fang W., Zhao P., Li H., Gu Z.
Disease area | Application area | Sample type | Products |
---|---|---|---|
Oncology | Technical Evaluation | Tissue Lysate | Olink Target 96 |
Abstract
T cell Lymph nodes are crucial organs of the adaptive immune system, orchestrating T cell priming, activation and tolerance. T cell activity and function are highly regulated by lymph nodes, which have a unique structure harbouring distinct cells that work together to detect and respond to pathogen-derived antigens. Here we show that implanted patient-derived freeze-dried lymph nodes loaded with chimeric antigen receptor T cells improve delivery to solid tumours and inhibit tumour recurrence after surgery. Chimeric antigen receptor T cells can be effectively loaded into lyophilized lymph nodes, whose unaltered meshwork and cytokine and chemokine contents promote chimeric antigen receptor T cell viability and activation. In mouse models of cell-line-derived human cervical cancer and patient-derived pancreatic cancer, delivery of chimeric antigen receptor T cells targeting mesothelin via the freeze-dried lymph nodes is more effective in preventing tumour recurrence when compared to hydrogels containing T-cell-supporting cytokines. This tissue-mediated cell delivery strategy holds promise for controlled release of various cells and therapeutics with long-term activity and augmented function.